MyoKardia - 49 Year Dividend History | MYOK
Historical dividend payout and yield for MyoKardia (MYOK) since 1971. The current TTM dividend payout for MyoKardia (MYOK) as of January 17, 2020 is $0.00. The current dividend yield for MyoKardia as of January 17, 2020 is 0.00%.
||Medical - Biomedical and Genetics
MyoKardia, Inc. is a biopharmaceutical company. The company focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its product candidate consists of MYK-461, a small molecule to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy, DCM-1, treats heritable dilated cardiomyopathy by restoring normal contractility in the diseased DCM heart, HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients and LUS-1, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart, which are in different clinical trial. MyoKardia, Inc. is headquartered in San Francisco, California.